Who owns FUSION PHARMACEUTICALS INC?
- Ticker: FUSN
- CUSIP Number: 36118a100
Tip: Access positions for across all investors
Analyze quarterly positions in Fusion Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Fusion Pharmaceuticals stock
Who bought or sold FUSION PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 11M | $105M | 2% | Dec 2023 |
|
| Avidity Partners Management | 6.5M | $63M | 12% | Dec 2023 |
|
| Deerfield Management Company | 6.4M | $62M | 127% | Dec 2023 |
|
| OrbiMed Advisors | 3.1M | $30M | 0% | Dec 2023 |
|
| Perceptive Advisors | 2.8M | $26M | 0% | Dec 2023 |
|
| Tpg Gp A | 2.6M | $25M | 0% | Dec 2023 |
|
| Sphera Funds Management | 1.1M | $10M | -20% | Dec 2023 |
|
| Artal Group | 1.0M | $9.7M | -42% | Dec 2023 |
|
| William Blair $ Company | 994k | $9.6M | 100% | Dec 2023 |
|
| Wellington Management Company | 745k | $7.2M | 100% | Dec 2023 |
|
| Eagle Health Investments | 580k | $5.6M | 0% | Dec 2023 |
|
| Millennium Management | 578k | $5.6M | -1% | Dec 2023 |
|
| Ikarian Capital | 500k | $4.8M | 100% | Dec 2023 |
|
| Marshall Wace | 318k | $3.1M | 100% | Dec 2023 |
|
| Fred Alger Management | 312k | $3.0M | 100% | Dec 2023 |
|
| Jennison Associates | 301k | $2.9M | 100% | Dec 2023 |
|
| Point72 Asset Management | 294k | $2.8M | -11% | Dec 2023 |
|
| Pier Capital | 277k | $2.7M | 100% | Dec 2023 |
|
| Walleye Trading Advisors | 251k | $2.4M | 100% | Dec 2023 |
|
| UBS Group | 223k | $2.1M | 139% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 154k | $1.5M | 100% | Dec 2023 |
|
| Privium Fund Management B.V. | 142k | $1.2M | 100% | Dec 2023 |
|
| HealthInvest Partners AB | 125k | $1.2M | 100% | Dec 2023 |
|
| Two Sigma Investments | 119k | $1.1M | 100% | Dec 2023 |
|
| Jump Financial | 86k | $828k | 100% | Dec 2023 |
|
| Yarbrough Capital | 77k | $1.6M | 0% | Mar 2024 |
|
| Citadel Advisors | 76k | $729k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 68k | $648k | 674600% | Dec 2023 |
|
| Raymond James & Associates | 52k | $497k | 100% | Dec 2023 |
|
| Chartwell Investment Partners | 50k | $480k | 100% | Dec 2023 |
|
| Superstring Capital Management | 46k | $440k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 35k | $332k | 721% | Dec 2023 |
|
| Raymond James Financial Services Advisors | 31k | $299k | 100% | Dec 2023 |
|
| Jane Street | 28k | $270k | 100% | Dec 2023 |
|
| Standard Life Aberdeen | 22k | $209k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 15k | $145k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 14k | $135k | 701550% | Dec 2023 |
|
| Squarepoint Ops | 13k | $123k | 100% | Dec 2023 |
|
| Simplex Trading | 13k | $120k | 15724% | Dec 2023 |
|
| Two Sigma Advisers | 12k | $111k | -64% | Dec 2023 |
|
| China Universal Asset Management | 8.4k | $80k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.6k | $64k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 5.0k | $48k | 100% | Dec 2023 |
|
| Signature | 2.9k | $28k | 883% | Dec 2023 |
|
| Cutler | 2.0k | $18k | 100% | Dec 2023 |
|
| Bank of America Corporation | 1.4k | $13k | -11% | Dec 2023 |
|
| Citigroup | 1.3k | $13k | 100% | Dec 2023 |
|
| TD Waterhouse Canada | 700.00 | $5.9k | 0% | Dec 2023 |
|
| Toth Financial Advisory Corporation | 501.00 | $11k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 86.00 | $826.004200 | 100% | Dec 2023 |
|
| GAMMA Investing | 26.00 | $554.000200 | 100% | Mar 2024 |
|
Who sold out of Fusion Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Weiss Multi-strategy Advisers | Dec 2023 | 172k | $1.7M |
| National Bank Of Canada /fi/ | Sep 2023 | 500.00 | $1.2k |